{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:33:53Z","timestamp":1793763233096,"version":"4.6.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ucl.2022.01.003","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T20:53:18Z","timestamp":1649796798000},"page":"273-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacologic Management of Interstitial Cystitis\/Bladder Pain Syndrome"],"prefix":"10.1016","volume":"49","author":[{"given":"Christopher J.","family":"Chermansky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina O.","family":"Guirguis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ucl.2022.01.003_bib1","first-page":"1545","article-title":"American urological association. Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment","volume":"193","author":"Hanno","year":"2015","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.ucl.2022.01.003_bib2","first-page":"1634","article-title":"Painful bladder filling and painful urgency are distinct characteristics in men and women with urological chronic pelvic pain syndromes: a MAPP research network study","volume":"194","author":"Lai","year":"2015","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.ucl.2022.01.003_bib3","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/nau.23072","article-title":"A\u00a0standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society","volume":"36","author":"Doggweiler","year":"2017","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1016\/j.ucl.2022.01.003_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1176\/ajp.35.4.574","article-title":"Diseases of the bladder and urethra in women","volume":"35","author":"Skene","year":"1879","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.ucl.2022.01.003_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00007611-191505000-00031","article-title":"A\u00a0rare type of bladder ulcer in women","volume":"8","author":"Hunner","year":"1915","journal-title":"South Med J"},{"issue":"4","key":"10.1016\/j.ucl.2022.01.003_bib6","first-page":"1358","article-title":"Interstitial cystitis\/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome","volume":"184","author":"Nickel","year":"2010","journal-title":"J\u00a0Urol"},{"issue":"S1","key":"10.1016\/j.ucl.2022.01.003_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/iju.13985","article-title":"Pathophysiology of interstitial cystitis","volume":"26","author":"Birder","year":"2019","journal-title":"Int J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2022.01.003_bib8","first-page":"1254","article-title":"Relationship between chronic nonurological associated somatic syndromes and symptom severity in urological chronic pelvic pain syndromes: Baseline evaluation of the MAPP study","volume":"193","author":"Krieger","year":"2015","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2022.01.003_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-016-0179-x","article-title":"The relationship between depression and overactive bladder\/urinary incontinence symptoms in the clinical OAB population","volume":"16","author":"Lai","year":"2016","journal-title":"BMC Urol"},{"issue":"2","key":"10.1016\/j.ucl.2022.01.003_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1152\/physrev.00030.2012","article-title":"Urothelial signaling","volume":"93","author":"Birder","year":"2013","journal-title":"Physiol Rev"},{"issue":"6","key":"10.1016\/j.ucl.2022.01.003_bib11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/iju.14229","article-title":"Interstitial cystitis\/bladder pain syndrome: the evolving landscape, animal models and future perspectives","volume":"27","author":"Akiyama","year":"2020","journal-title":"Int J Urol"},{"issue":"5","key":"10.1016\/j.ucl.2022.01.003_bib12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.mayocp.2015.03.014","article-title":"Fibromyalgia and related conditions","volume":"90","author":"Clauw","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.ucl.2022.01.003_bib13","first-page":"845","article-title":"A\u00a0quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate","volume":"150","author":"Parsons","year":"1993","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.ucl.2022.01.003_bib14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0090-4295(90)80116-5","article-title":"Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study","volume":"35","author":"Mulholland","year":"1990","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2022.01.003_bib15","first-page":"503","article-title":"A\u00a0prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease","volume":"138","author":"Holm-Bentzen","year":"1987","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib16","first-page":"857","article-title":"Pentosan polysulfate sodium for treatment of interstitial cystitis\/bladder pain syndrome: Insights from a randomized, double-blind, placebo controlled study","volume":"193","author":"Nickel","year":"2015","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib17","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Opthalmology"},{"key":"10.1016\/j.ucl.2022.01.003_bib18","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ophtha.2019.04.024","article-title":"Strength of association between pentosan polysulfate and a novel maculopathy","volume":"126","author":"Hanif","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ucl.2022.01.003_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ophtha.2019.10.036","article-title":"Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States","volume":"127","author":"Ludwig","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ucl.2022.01.003_bib20","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/bjophthalmol-2019-314765","article-title":"Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort","volume":"104","author":"Jain","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ucl.2022.01.003_bib21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ophtha.2020.01.017","article-title":"Prevalence of maculopathy associated with long-term pentosan polysulfate therapy","volume":"127","author":"Vora","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ucl.2022.01.003_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcjo.2019.12.003","article-title":"A\u00a0path to the development of screening guidelines for pentosan maculopathy","volume":"55","author":"Sadda","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ucl.2022.01.003_bib23","first-page":"533","article-title":"A\u00a0prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis","volume":"172","author":"van Ophoven","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib24","first-page":"1837","article-title":"Long-term results of amitriptyline treatment for interstitial cystitis","volume":"174","author":"van Ophoven","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib25","first-page":"1853","article-title":"Effect of amitriptyline on symptoms in treatment na\u00efve patients with interstitial cystitis\/painful bladder syndrome","volume":"183","author":"Foster","year":"2010","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib26","first-page":"810","article-title":"A\u00a0pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis","volume":"170","author":"Sant","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0090-4295(97)00182-9","article-title":"Hydroxyzine therapy for interstitial cystitis","volume":"49","author":"Theoharides","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2022.01.003_bib28","first-page":"1591","article-title":"Cyclosporine in severe interstitial cystitis","volume":"155","author":"Forsell","year":"1996","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib29","first-page":"2138","article-title":"Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A","volume":"171","author":"Sairanen","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib30","first-page":"2235","article-title":"Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study","volume":"174","author":"Sairanen","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib31","first-page":"1186","article-title":"Cyclosporine A for refractory interstitial cystitis\/bladder pain syndrome: experience of 3 tertiary centers","volume":"188","author":"Forrest","year":"2012","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/21681805.2013.788552","article-title":"Nitric oxide as a marker for evaluation of treatment effect of cyclosporine A in patients with bladder pain syndrome\/interstitial cystitis type 3C","volume":"47","author":"Ehr\u00e9n","year":"2013","journal-title":"Scand J Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.urology.2017.05.016","article-title":"Efficacy, side effects, and monitoring of oral cyclosporine in interstitial cystitis-bladder pain syndrome","volume":"107","author":"Crescenze","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2022.01.003_bib34","first-page":"36","article-title":"A\u00a0controlled study of dimethyl sulfoxide in interstitial cystitis","volume":"140","author":"Perez-Marrero","year":"1988","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/iju.14505","article-title":"Efficacy and safety of intravesical instillation of KRP-116D (50% dimethyl sulfoxide solution) for interstitial cystitis\/bladder pain syndrome in Japanese patients: A multicenter, randomized, double-blind, placebo-controlled, clinical study","volume":"28","author":"Yoshimura","year":"2021","journal-title":"Int J Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib36","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1464-410X.2008.08162.x","article-title":"Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome","volume":"103","author":"Nickel","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.ucl.2022.01.003_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.urology.2004.08.056","article-title":"Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis","volume":"65","author":"Parsons","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2022.01.003_bib38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1464-410X.1994.tb07634.x","article-title":"Treatment of interstitial cystitis with intravesical heparin","volume":"73","author":"Parsons","year":"1994","journal-title":"Br J Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib39","first-page":"309","article-title":"Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis","volume":"100","author":"Kuo","year":"2001","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.ucl.2022.01.003_bib40","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/iju.12120","article-title":"On- and post-treatment symptom relief by repeated instillations of heparin and alkalized lidocaine in interstitial cystitis","volume":"20","author":"Nomiya","year":"2013","journal-title":"Int J Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib41","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00192-008-0560-8","article-title":"The effects of intravesical pentosanpolysulfate treatment on the symptoms of patients with bladder pain syndrome\/interstitial cystitis: preliminary results","volume":"19","author":"Daha","year":"2008","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.ucl.2022.01.003_bib42","first-page":"177","article-title":"Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial","volume":"179","author":"Davis","year":"2008","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib43","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1464-410X.2009.08495.x","article-title":"Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis\/painful bladder syndrome","volume":"104","author":"Kuo","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.ucl.2022.01.003_bib44","first-page":"197","article-title":"Intravesical onabotulinumtoxin A injections for refractory painful bladder syndrome","volume":"15","author":"Chung","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.ucl.2022.01.003_bib45","first-page":"548","article-title":"Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome\/interstitial cystitis","volume":"189","author":"Pinto","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib46","first-page":"109","article-title":"Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis","volume":"16","author":"Lee","year":"2013","journal-title":"Pain Physician"},{"key":"10.1016\/j.ucl.2022.01.003_bib47","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.eururo.2018.07.026","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of certolizumab pegol in women with refractory interstitial cystitis\/bladder pain syndrome","volume":"74","author":"Bosch","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2022.01.003_bib48","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00192-020-04659-w","article-title":"Efficacy and safety comparison of pharmacotherapies for interstitial cystitis and bladder pain syndrome: a systematic review and Bayesian network meta-analysis","volume":"32","author":"Di","year":"2021","journal-title":"Int Urogynecol J"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014322000039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014322000039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:55:24Z","timestamp":1758808524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014322000039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0094014322000039"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2022.01.003","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic Management of Interstitial Cystitis\/Bladder Pain Syndrome","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2022.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}